Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Echo IQ.
RELATED STOCKHEAD STORIES
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
Dr Boreham’s Crucible: Can this aortic stenosis detection specialist keep things pumping post FDA approval?
Health & Biotech
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
News
Closing Bell: ASX up but MinRes slumps on lithium downgrade; China stocks also sink
Health & Biotech
Health Check: Fresh from its FDA win, Echo IQ aims for even bigger heart failure approval
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Arcadium soars 47pc as Rio makes move; retailers beg RBA to cut rates before Christmas
Health & Biotech
Health Check: The Winner Takes It All as US investors back advanced biotech plays
Health & Biotech
Alive and Kicking: Noxopharm has difficult brain cancer in its sights
News
Rise and Shine: Everything you need to know before the ASX opens
News
Market Highlights: Wall Street at record high as Nvidia surpasses Apple; and 5 small caps to watch today
Health & Biotech
With FDA approval close, Echo IQ’s AI platform is set to disrupt US heart disease market
News
ASX Small Caps and IPO Weekly Wrap: Goldies ruled the roost as we got teased by a 10-bagger
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX rebounds as soft CPI bolsters August rate cut hopes; OSX and TLM lead today’s winners
News
ASX Small Caps Lunch Wrap: Osteopore’s gone 1000% bananas, and here’s the rest of the news.
Health & Biotech